{
  "id": "553fa78b1d53b76422000007",
  "type": "list",
  "question": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?",
  "ideal_answer": "miR-200a, miR-100, miR-141, miR-200b, miR-200c, miR-203, miR-510, miR-509-5p, miR-132, miR-26a, let-7b, miR-145, miR-182, miR-152, miR-148a, let-7a, let-7i, miR-21, miR-92 and miR-93 could be used as potential biomarkers for epithelial ovarian cancer.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/21345725",
    "http://www.ncbi.nlm.nih.gov/pubmed/22246341",
    "http://www.ncbi.nlm.nih.gov/pubmed/23888941",
    "http://www.ncbi.nlm.nih.gov/pubmed/23836287",
    "http://www.ncbi.nlm.nih.gov/pubmed/23542579",
    "http://www.ncbi.nlm.nih.gov/pubmed/20035894",
    "http://www.ncbi.nlm.nih.gov/pubmed/19074899",
    "http://www.ncbi.nlm.nih.gov/pubmed/23978303",
    "http://www.ncbi.nlm.nih.gov/pubmed/18954897",
    "http://www.ncbi.nlm.nih.gov/pubmed/21571355",
    "http://www.ncbi.nlm.nih.gov/pubmed/21971665",
    "http://www.ncbi.nlm.nih.gov/pubmed/23918241",
    "http://www.ncbi.nlm.nih.gov/pubmed/23272653",
    "http://www.ncbi.nlm.nih.gov/pubmed/23621186"
  ],
  "snippets": [
    {
      "text": "Finally, five promising differentially miRNAs (miR-200a, miR-100, miR-141, miR-200b, and miR-200c) were reported with the consistent direction in four or more studies. MiR-200a, miR-200b, miR-200c, and miR-141, all of them belong to miR-200 family, were reported with consistently up-regulated in at least 4 studies, whereas miR-100 was reported with down-regulated in 4 studies",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23978303",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Upregulation of microRNA-203 is associated with advanced tumor progression and poor prognosis in epithelial ovarian cancer",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23918241",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "multivariate analysis showed that the status of miR-203 expression was an independent predictor for both overall survival and progression-free survival in EOC. These findings provide the convincing evidence for the first time that the upregulation of miR-203 may serve as a novel molecular marker to predict the aggressive tumor progression and unfavorable prognosis of EOC patients",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23918241",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Some, but not all, of the data indicated that the miR-200 family was dysregulated in a variety of malignancies. In this study, we demonstrated that miR-200a and E-cadherin were significantly upregulated in EOC compared to benign epithelial ovarian cysts and normal ovarian tissues",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23888941",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "There was a significantly positive correlation between miR-200a and E-cadherin in EOC. The biphasic expression pattern suggested that miR-200a levels may serve as novel biomarkers for the early detection of EOC, and miR-200a and E-cadherin are candidate targets for the development of new treatment modalities against ovarian cancer",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23888941",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Kaplan-Meier analysis showed low miR-510 expression, low miR-509-5p expression, and advanced FIGO stage, and chemotherapy resistance were significantly associated with poorer overall survival (P < 0.05). Our results suggest that miRNAs may play a role in the progression of OSC, and miR-510 and miR-509-5p may be considered novel-candidate clinical biomarkers for predicting OSC outcome",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23836287",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The qRT-PCR results showed that miR-510, miR-509-5p, and miR-508-3p were significantly downregulated and that miR-483-5p was upregulated in stage III OSC compared with stage I, which was consistent with the microarray results",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23836287",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In this study, we examined serum miR-21 levels in epithelial ovarian cancer (EOC) patients, and explored its association with clinicopathological factors and prognosis. The results showed significantly higher serum miR-21 levels in EOC patients than in healthy controls. In addition, increased serum miR-21 expression was correlated with advanced FIGO stage, high tumor grade, and shortened overall survival. These findings indicate that serum miR-21 may serve as a novel diagnostic and prognostic marker, and be used as a therapeutic target for the treatment of EOC",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23621186",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Identification of serum microRNA-21 as a biomarker for early detection and prognosis in human epithelial ovarian cancer",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23621186",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Serum miR-132, miR-26a, let-7b, and miR-145 could be considered as potential candidates as novel biomarkers in serous ovarian cancer.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23542579",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Among the miRNAs that showed a consistent regulation tendency through all specimens and showed more than a 2-fold difference in serum, 5 miRNAs (miR-132, miR-26a, let-7b, miR-145, and miR-143) were determined as the 5 most markedly down-regulated miRNAs in the serum from ovarian cancer patients with respect to those of controls. Four miRNAs (miR-132, miR-26a, let-7b, and miR-145) out of 5 selected miRNAs were significantly underexpressed in the serum of ovarian cancer patients in qRT-PCR",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23542579",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " microRNA (miR)-182, miR-200a, miR-200b and miR-200c were highly overexpressed in the SEOC cell lines relative to normal human ovarian surface epithelial cells and were assessed in RNA extracted from serum as candidate biomarkers",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23272653",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Together, these results suggest that low miR-100 expression             may be an independent poor prognostic factor and miR-100 can function as a tumor             suppressor by targeting PLK1 in human EOCs",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22246341",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Prognostic implications of microRNA-100 and its functional roles in             human epithelial ovarian cancer",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22246341",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Taken together, miR-152 and miR-148a may be involved             in the carcinogenesis of ovarian cancer through deregulation of cell proliferation.             They may be novel biomarkers for early detection or therapeutic targets of ovarian             cancer",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21971665",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "MicroRNA let-7a: a potential marker for selection of paclitaxel in ovarian cancer management",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21571355",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": " The study suggests that the beneficial impact of the addition of paclitaxel on EOC survival was significantly linked to let-7a levels, and that miRNAs such as let-7a may be a useful marker for selection of chemotherapeutic agents in EOC management",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21571355",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "miR-200c has potential as a predictor of survival, and is a biomarker of relapse, in stage I EOC",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21345725",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19074899",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": " our results strongly suggest that let-7i might be used as a therapeutic target to modulate platinum-based chemotherapy and as a biomarker to predict chemotherapy response and survival in patients with ovarian cancer",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19074899",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "miRNAs-21, 92 and 93 are known oncogenes with therapeutic and biomarker potential",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18954897",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Serum miR-132, miR-26a, let-7b, and miR-145 could be considered as potential candidates as novel biomarkers in serous ovarian cancer",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23542579",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [
    "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D035683",
    "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D015415",
    "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D010051",
    "http://www.disease-ontology.org/api/metadata/DOID:2394"
  ],
  "exact_answer": "let-7a, let-7b, let-7i, miR-21, miR-26a, miR-92, miR-93, miR-100, miR-132, miR-141, miR-145, miR-148a, miR-152, miR-182, miR-200a, miR-200b, miR-200c, miR-203, miR-509-5p, miR-510"
}